TY - JOUR
T1 - Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?
AU - Harris, Rachel L.
AU - Harrison, Christine J.
AU - Martineau, Mary
AU - Taylor, Kerry E.
AU - Moorman, Anthony V.
N1 - Funding Information:
The authors would like to thank the Leukaemia Research Fund for financial support; the Clinical Trial Service Unit at the University of Oxford for providing clinical and survival data; and the laboratories of the UK Cancer Cytogenetics Group, who provided cytogenetic data, FISH results and/or fixed cell suspensions: Department of Academic Haematology and Cytogenetics, Royal Marsden NHS Trust, Surrey; Department of Cytogenetics, St. James University Hospital Trust, Leeds; Department of Cytogenetics, Western General Hospital, Edinburgh; Department of Haematology, Addenbrooke's NHS Trust, Cambridge; Department of Haematology, University College Hospital, London; South West Regional Cytogenetics Centre, United Bristol Healthcare NHS Trust; West Midlands Regional Genetics Service, Birmingham Women's Hospital.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2004/1/15
Y1 - 2004/1/15
N2 - Acute lymphoblastic leukemia (ALL) is characterized by recurrent clonal chromosomal abnormalities, with numerical abnormalities being a common feature especially among children. Case reports in the literature suggest that one such recurrent numerical abnormality is the gain of chromosome 5 (trisomy 5) as the sole abnormality; due to the rarity of these cases, however, little is known about their incidence, clinical features, and prognosis. We have identified seven cases with trisomy 5 as the sole or primary chromosomal abnormality from a total of 3,400 karyotypes collected in the Leukaemia Research Fund UK Cancer Cytogenetics Group Karyotype Database. All cases had a precursor B-cell immunophenotype and there was a male predominance. Five patients were children aged between 7 and 14 years old. Four of the six patients with a reasonable follow-up period had relapsed, indicating a poor prognosis. We conclude that trisomy 5 as the sole numerical abnormality occurs predominantly in older children, may be associated with a poor outcome, and may represent a distinct, albeit rare, cytogenetic subgroup in ALL.
AB - Acute lymphoblastic leukemia (ALL) is characterized by recurrent clonal chromosomal abnormalities, with numerical abnormalities being a common feature especially among children. Case reports in the literature suggest that one such recurrent numerical abnormality is the gain of chromosome 5 (trisomy 5) as the sole abnormality; due to the rarity of these cases, however, little is known about their incidence, clinical features, and prognosis. We have identified seven cases with trisomy 5 as the sole or primary chromosomal abnormality from a total of 3,400 karyotypes collected in the Leukaemia Research Fund UK Cancer Cytogenetics Group Karyotype Database. All cases had a precursor B-cell immunophenotype and there was a male predominance. Five patients were children aged between 7 and 14 years old. Four of the six patients with a reasonable follow-up period had relapsed, indicating a poor prognosis. We conclude that trisomy 5 as the sole numerical abnormality occurs predominantly in older children, may be associated with a poor outcome, and may represent a distinct, albeit rare, cytogenetic subgroup in ALL.
UR - http://www.scopus.com/inward/record.url?scp=0347899407&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0347899407&partnerID=8YFLogxK
U2 - 10.1016/S0165-4608(03)00272-3
DO - 10.1016/S0165-4608(03)00272-3
M3 - Article
C2 - 14734231
AN - SCOPUS:0347899407
SN - 0165-4608
VL - 148
SP - 159
EP - 162
JO - Cancer Genetics and Cytogenetics
JF - Cancer Genetics and Cytogenetics
IS - 2
ER -